Therapeutics

400+ Companies
Companies
480
Established hub
Deals 2022 Q2
No investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
MedCity News

GSK pays $100M to partner on a cancer drug with new twist on immunotherapy

ABC News , MedCity News

Pfizer buying spree continues with $5.4B hematology deal

Pulse 2.0

Karuna Therapeutics (KRTX) Stock: Why It Increased Over 50% Today

Pulse 2.0

Nektar Therapeutics (NKTR) Stock: Why It Fell Over 3% Today

Pulse 2.0

Why Pfizer (PFE) Is Buying Global Blood Therapeutics (GBT) For $5.4 Billion

Reuters Top News

Pfizer in advanced talks to buy Global Blood Therapeutics for $5 billion, Wall Street Journal reports

Pulse 2.0

Avalo Therapeutics (AVTX) Stock: Why It Increased 10.96%

Pulse 2.0

Global Blood Therapeutics (GBT) Stock: Why It Surged Over 35% Today

Pulse 2.0

Poseida Therapeutics (PSTX) Stock: Why It Surged 85.6% 

Pulse 2.0

Kintara Therapeutics (KTRA) Stock: Why It Surged 38.26% Today

MedCity News

Ipsen’s latest R&D alliance brings novel T cell-activating drugs for cancer

Pulse 2.0

Structure Therapeutics Closes $33 Million Funding As Series B Extension

Pulse 2.0

Protein Stabilization Company Vicinitas Therapeutics Has Raised $65 Million In Series A

Pulse 2.0

Beam Therapeutics (BEAM) Stock: Why It Fell Over 3% Today

MedCity News

FDA hits pause on Beam Therapeutics’ off-the-shelf cell therapy for blood cancers

MedCity News

Novartis, UC Berkeley-spawned startup snags $65M to keep key proteins from the cell’s trash can

Pulse 2.0

Pliant Therapeutics (PLRX) Stock: $33 Target And Outperform Rating

Pulse 2.0

Sarepta Therapeutics (SRPT) Stock: Why It Increased Over 12% Today

Pulse 2.0

Better Therapeutics (BTTX) Stock: Why It Surged Over 50% Today

MedCity News

Diabetes care need to support lifestyle changes – not pharmaceutical intervention – first